Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Allogene Therapeutics (ALLO) has a market cap of $0.32 billion USD. According to our data, Allogene Therapeutics is ranked No.6455 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.32 B |
-28.97%
|
| Dec 31, 2024 | $0.45 B |
-33.64%
|
| Dec 29, 2023 | $0.67 B |
-48.97%
|
| Dec 30, 2022 | $1.32 B |
-57.84%
|
| Dec 31, 2021 | $3.13 B |
-40.89%
|
| Dec 31, 2020 | $5.29 B |
-2.85%
|
| Dec 31, 2019 | $5.45 B |
-3.53%
|
| Dec 31, 2018 | $5.65 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
 Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
USA
|
 Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
 Atara Biotherapeutics
ATRA
|
$35.04 M |
-0.000 M
|
USA
|
 Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
UK
|
 Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
USA
|
 Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
USA
|
| Market Cap | = | ALLO Stock Price | * | ALLO Shares Outstanding |
| = | $1.46 | * | 0.22 B | |
| = | $0.32 B |